Henry O. Gosebruch - 19 Sep 2023 Form 4 Insider Report for Neumora Therapeutics, Inc. (NMRA)

Role
President & CEO, Director
Signature
/s/ Joshua Pinto, as Attorney-in-Fact for Henry O. Gosebruch
Issuer symbol
NMRA
Transactions as of
19 Sep 2023
Transactions value $
$189,371
Form type
4
Filing time
19 Sep 2023, 21:47:02 UTC
Previous filing
14 Sep 2023
Next filing
16 Feb 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NMRA Common Stock Purchase $189K +15K $12.62* 15K 19 Sep 2023 See Footnote F1, F2
holding NMRA Common Stock 127K 19 Sep 2023 See Footnote F3
holding NMRA Common Stock 382K 19 Sep 2023 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $12.465 to $12.65, inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares purchased at each respective price within the range set forth in this footnote.
F2 Shares held by HG4KYC TRUST, of which Reporting Person is trustee.
F3 Shares held by Lu Leng Felicia Chua Descendants 2012 Irrevocable Trust, of which Reporting Person is trustee.